Abstract
Being one of the main stem cell therapy meetings of the year, the Sixth International Symposium on Stem Cell Therapy and Cardiovascular Innovations was held on April 23rd–24th, 2009, at the Auditorium of the High Council of Scientific Research of Spain (CSIC) in Madrid. Gathering the most prestigious basic researchers and clinical experts in the field of cardiovascular regenerative medicine, the aim of the meeting was to discuss the available evidence and the recent contributions from preclinical investigators, cardiologists, and cardiac surgeons in a participative translational fashion. The role of young “clinician scientists” was reinforced with a special poster session and three awards. The main conclusions of the symposium were (1) that standardization, larger clinical trials, and true translational research are needed, and (2) that new—allogeneic—stem cell products, biotechnological devices, and cell-based bioartificial organs are potentially exciting options for the future.
Similar content being viewed by others
References
Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation, 120(5), 408–416.
Passier, R., van Laake, L. W., & Mummery, C. L. (2008). Stem-cell-based therapy and lessons from the heart. Nature, 453(7193), 322–329.
Van’t Hof, W., Mal, N., Huang, Y., Zhang, M., Popovic, Z., Forudi, F., et al. (2007). Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. Cytotherapy, 9(5), 477–87.
Drukker, M., Katz, G., Urbach, A., Schuldiner, M., Markel, G., Itskovitz-Eldor, J., et al. (2002). Characterization of the expression of MHC proteins in human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 99(15), 9864–9869.
Swijnenburg, R. J., Tanaka, M., Vogel, H., Baker, J., Kofidis, T., Gunawan, F., et al. (2005). Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation, 112(9 Suppl), I166–I172.
Swijnenburg, R. J., Schrepfer, S., Govaert, J. A., Cao, F., Ransohoff, K., Sheikh, A. Y., et al. (2008). Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proceedings of the National Academy of Sciences of the United States of America, 105(35), 12991–12996.
Cheng, Z., Ou, L., Zhou, X., Li, F., Jia, X., Zhang, Y., et al. (2008). Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Molecular Therapy, 16(3), 571–579.
Pasha, Z., Wang, Y., Sheikh, R., Zhang, D., Zhao, T., & Ashraf, M. (2008). Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovascular Research, 77(1), 134–142.
Zhang, M., Mal, N., Kiedrowski, M., Chacko, M., Askari, A. T., Popovic, Z. B., et al. (2007). SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes following myocardial infarction. FASEB Journal, 21(12), 3197–3207.
Meyer, G. P., Wollert, K. C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., et al. (2006). Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 113(10), 1287–1294.
Piao, H., Kwon, J. S., Piao, S., Sohn, J. H., Lee, Y. S., Bae, J. W., et al. (2007). Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials, 28(4), 641–649.
Cortes-Morichetti, M., Frati, G., Schussler, O., Van Huyen, J. P., Lauret, E., Genovese, J. A., et al. (2007). Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Engineering, 13(11), 2681–2687.
Chachques, J. C., Trainini, J. C., Lago, N., Cortes-Morichetti, M., Schussler, O., & Carpentier, A. (2008). Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM Trial): Clinical feasibility study. Annals of Thoracic Surgery, 85(3), 901–908.
Schussler, O., Coirault, C., Louis-Tisserand, M., Al-Chare, W., Oliviero, P., Menard, C., et al. (2009). Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nature Clinical Practice Cardiovascular Medicine, 6(3), 240–249.
Dégano, I. R., Quintana, L., Vilalta, M., Horna, D., Rubio, N., Borrós, S., et al. (2009). The effect of self-assembling peptide nanofiber scaffolds on mouse embryonic fibroblast implantation and proliferation. Biomaterials, 30(6), 1156–1165.
Genovese, J. A., Spadaccio, C., Chachques, E., Schussler, O., Carpentier, A., Chachques, J. C., et al. (2009). Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. Frontiers in Bioscience, 14, 2996–3002.
Jaski, B. E., Jessup, M. L., Mancini, D. M., Cappola, T. P., Pauly, D. F., Greenberg, B., et al. (2009). Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. Journal of Cardiac Failure, 15(3), 171–181.
Van Rooij, E., Marshall, W. S., & Olson, E. N. (2008). Toward microRNA-based therapeutics for heart disease: The sense in antisense. Circulation Research, 103(9), 919–928.
Jones, R. H., Velazquez, E. J., Michler, R. E., Sopko, G., Oh, J. K., O’Connor, C. M., et al. (2009). Coronary bypass surgery with or without surgical ventricular reconstruction. New England Journal of Medicine, 360(17), 1705–1717.
Lietz, K. & Miller, L. W. (2008). Destination therapy: Current results and future promise. Seminars in Thoracic and Cardiovascular Surgery, 20(3), 225–233.
Hernandez, A. F., Shea, A. M., Milano, C. A., Rogers, J. G., Hammill, B. G., O’Connor, C. M., et al. (2008). Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. Journal of the American Medical Association, 300(20), 2398–2406.
Yacoub, M. (2008). Heart transplantation: The end of the beginning. American Journal of Transplantation, 8(9), 1767–1768.
Ali, A. A., Lim, E., Thanikachalam, M., Sudarshan, C., White, P., Parameshwar, J., et al. (2007). Cardiac arrest in the organ donor does not negatively influence recipient survival after heart transplantation. European Journal of Cardio-Thoracic Surgery, 31(5), 929–933.
Vincenti, F. & Kirk, A. D. (2008). What’s next in the pipeline. American Journal of Transplantation, 8(10), 1972–1981.
Cozzi, E., Bosio, E., Seveso, M., Rubello, D., & Ancona, E. (2009). Xenotransplantation as a model of integrated, multidisciplinary research. Organogenesis, 5(1), 288–296.
Lederman, R. J., Guttman, M. A., Peters, D. C., Thompson, R. B., Sorger, J. M., Dick, A. J., et al. (2002). Catheter-based endomyocardial injection with real-time magnetic resonance imaging. Circulation, 105(11), 1282–1284.
De Silva, R., Gutierrez, L. F., Raval, A. N., McVeigh, E. R., Ozturk, C., & Lederman, R. J. (2006). X-ray fused with magnetic resonance imaging (XFM) to target endomyocardial injections. Validation in a swine model of myocardial infarction. Circulation, 114(25), 2342–2350.
Taylor, D. A. (2009). Cells for the treatment, prevention, and cure of cardiovascular disease. Texas Heart Institute Journal, 3(2), 148–149.
Zenovich, A. G. & Taylor, D. A. (2008). Atherosclerosis as a disease of failed endogenous repair. Frontiers in Bioscience, 13, 3621–3636.
Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet, 364(9424), 141–148.
Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New England Journal of Medicine, 355(12), 1210–1221.
Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. New England Journal of Medicine, 355(12), 1199–1209.
Huikuri, H. V., Kervinen, K., Niemelä, M., Ylitalo, K., Säily, M., Koistinen, P., et al. (2008). Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. European Heart Journal, 29(22), 2723–2732.
Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet, 367(9505), 113–121.
Abdel-Latif, A., Bolli, R., Tleyjeh, I. M., Montori, V. M., Perin, E. C., Hornung, C. A., et al. (2007). Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Archives of Internal Medicine, 167(10), 989–997.
Lipinski, M. J., Biondi-Zoccai, G. G., Abbate, A., Khianey, R., Sheiban, I., Bartunek, J., et al. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. Journal of the American College of Cardiology, 50(18), 1761–1767.
Burt, R. K., Loh, Y., Pearce, W., Beohar, N., Barr, W. G., Craig, R., et al. (2008). Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. Journal of the American Medical Association, 299(8), 925–936.
Tendera, M., Wojakowski, W., Ruzyłło, W., Chojnowska, L., Kepka, C., Tracz, W., et al. (2009). Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: Results of randomized, multicentre myocardial regeneration by intracoronary infusion of selected population of stem cells in acute myocardial infarction (REGENT) trial. European Heart Journal, 30(11), 1313–1321.
Van der Laan, A., Hirsch, A., Nijveldt, R., Van der Vleuten, P. A., Van der Giessen, W. J., Doevendans, P. A., et al. (2008). Bone marrow cell therapy after acute myocardial infarction: The HEBE Trial in perspective, first results. Netherlands Heart Journal, 16(12), 436–439.
Menasché, P. (2009). Cell based therapy for heart disease: A clinically oriented perspective. Molecular Therapy, 17(5), 758–766.
Richter, S. H., Garner, J. P., & Würbel, H. (2009). Environmental standardization: Cure or cause of poor reproducibility in animal experiments? Nature Methods, 6(4), 257–261.
Acknowledgments
This work was supported by the ISCIII-RETIC RD06/ 0014 RECAVA. We thank the Spanish Cooperative Cardiovascular Disease Research Network (RECAVA, Red Temática de Investigación Cooperativa en Enfermedades Cardiovasculares) and the Spanish Cell Therapy Research Network (TERCEL, Red Temática de Terapia Celular from the Instituto de Salud Carlos III, ISCIII) for their sponsorship. We also appreciate the efforts of the members of the Task Force of the European Society and the members of the local executive committee of the Symposium. We would like to thank Ana Fernández-Baza for her technical direction and invaluable help in organizing the Symposium.
Conflict of interest statement
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vázquez-Álvarez, M.E., Sanz-Ruiz, R., Gutiérrez, E. et al. General Overview of the Sixth International Symposium on Stem Cell Therapy and Cardiovascular Innovations. J. of Cardiovasc. Trans. Res. 3, 1–7 (2010). https://doi.org/10.1007/s12265-009-9156-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-009-9156-z